Rh condition
A person who is Rh+ has a protein coating (antigen) on his or her red blood cells. normal.
-> person who is Rh- have normal RBCs too but lack the Rh factor antigen
second pregnancy with Rh- mom and Rh+ dad and the baby is Rh+
if this embryo is Rh+, during pregnancy the mothers acquired antibodies (from the first pregnancy) enter the embryo’s blood stream. These antibodies attack and destroy the embryo’s Rh+ RBCs (hemolysis)
-> infant is then born with hemolytic disease of the newborn (HDN)
HDN- hemolytic disease of the newborn
-Physicians administer Rh immunoglobulin to an Rh− woman within 72 hours after each Rh+ delivery, abortion, or miscarriage. The globulin binds to Rh+ cells that escape into the mother’s circulation and prevents formation of Rh+ antibodies.
anomaly
is an irregularity in a structure or organ
-> congenital anomaly
congenital anomaly
CRISPR
new DNA editing tool that changes DNA sequences to turn off genes or to replace them with new versions. CRISPR means clustered regularly-interspaced short palindromic repeats
recombinant DNA tech
is the process of taking a gene (a region of DNA) from one organism and inserting it into the DNA of another organism.
syndrome
is a group of signs or symptoms that appear together to produce a typical clinical picture of a disease or inherited abnormality
reye syndrome
marfan syndrome
an inherited connective tissue disorder marked by a tall, thin body type with long, “spidery” fingers and toes (arachnodactyly), elongated head, and heart, blood vessel, and ophthalmic abnormalities
transurethral resection of the prostate gland (TURP) procedure
ultrasonography
a diagnostic technique using ultrasound waves to produce an image of an organ or tissue
echocardiograms
ultrasound images of the heart
Anemia
-> big problem for patients in chronic renal failure bc kidneys secrete less erythropoietin
epoetin alfa (epogen or procrit)
man-made form of human erythropoietin
-genetically engineered through recombinant DNA technology and stimulates bone marrow to make and release red blood cells
side effects of myelosuppresive chemotherapy may be treated by
epogen, neupogen, and thrombopoietin